Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / RDY - Dr. Reddy's: Underappreciated Future Amid Exaggerated Headwinds


RDY - Dr. Reddy's: Underappreciated Future Amid Exaggerated Headwinds

2025-10-29 14:02:12 ET

I wrote my initial thesis on Dr. Reddy’s Laboratories ( RDY ) in January 2025. At that time I rated RDY a strong buy owing to its lucrative valuation compared to industry peers. As the market does not offer a free lunch, this discount was also backed by a solid headwind primarily stemming from the expected revenue cliff-off from the patent expiration and subsequent competition for one of the star drugs, Revlimid....

For further details see:

Dr. Reddy's: Underappreciated Future Amid Exaggerated Headwinds

Stock Information

Company Name: Dr. Reddy's Laboratories Ltd
Stock Symbol: RDY
Market: NYSE
Website: drreddys.com

Menu

RDY RDY Quote RDY Short RDY News RDY Articles RDY Message Board
Get RDY Alerts

News, Short Squeeze, Breakout and More Instantly...